All UK & Rest of Europe articles – Page 65
-
NewsUK launches £65 million funding call for space technologies and applications
The UK Space Agency has announced up to £65 million of funding for ground-breaking innovations that could boost UK leadership in space technologies and applications. The National Space Innovation Programme (NSIP) will support high-risk, high-reward projects designed by British organisations with the potential to accelerate the ...
-
NewsMainstay malaria drug may be beginning to fail in the Horn of Africa
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.
-
NewsInfamous ‘eagle killer’ cyanobacterium produces not one, but two toxins
Two years ago, researchers established that a toxin from the cyanobacterium Aetokthonos hydrillicola is the cause of a mysterious disease among bald eagles in the USA - now they have described an elusive second toxin.
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsHERV-W virus acting as neuropathogen successfully confirmed
Scientists have described a direct functional connection between the release of an endogenous retrovirus and the worsening of neurodegenerative processes in multiple sclerosis.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsAntibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
-
NewsResearchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at ...
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsCOVID-19 could hold key to spotting viruses with pandemic potential
Certain SARS-CoV-2 variants of concern are evolving to do a better job of shutting down human innate immune responses, according to new research.
-
CareersEdie uncovers how microbes can shine light on dirt bike vandalism
For her AMI-sponsored Summer Placement, forensic science student Edie Holmes joined a team investigating whether microbial profiling could be used to link dirt bikes to vandalised sites of special scientific interest (SSSIs). Here’s what happened.
-
NewsSyphilis transmission networks and AMR in England uncovered using genomics
Scientists use genomics to uncover syphilis transmission patterns in England, in a pioneering new approach for STI surveillance.
-
NewsMilestone in the fight against pandemics
Researchers at TU Dresden create pioneering approaches for the detection of viral antigens.
-
News25 new phage viruses IDed in Barcelona’s wastewaters
Scientists have identified 25 new viruses that infect bacteria in the human intestinal tract in wastewaters around the city’s metropolitan area and in some towns nearby.
-
NewsNew SARS-CoV-2 variant Eris on the rise
The EG.5 lineage of SARS-CoV-2, known as Eris, which has been spreading globally, has been found to be able to escape neutralizing antibodies better than other currently circulating SARS-CoV-2 lineages.
-
CareersEarly career scientists team up with biotech firm NCIMB to tackle pesticide toxicity
Biotech company NCIMB, one of the industrial beneficiaries, recently hosted three early career scientists as part of the ARISTO programme which aims to develop tools to assess the toxicity of pesticides on soil microorganisms.
-
NewsResearchers awarded €1.2 million to commercialise cultivated meat
Companies have received €1.2 million in additional funding from EIT Food to develop innovative products to reduce the cost of producing cultivated meat within the next two years.
-
NewsMajority rule in complex mixtures
Göttingen University researchers use mathematical model to identify new mechanism for control of phase separation.
-
NewsBacteria resistant to antibiotics found in hospital wastewater system
A unique new study led by researchers at University of Limerick in Ireland has found that bacteria that may lead to hospital acquired infection is present in a hospital’s wastewater system.